Top Tech Companies (2,089)
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer. Read more about Immatics on our homepage: https://immatics.com/ Find us also on: Twitter: https://twitter.com/immatics Instagram: https://www.instagram.com/immatics/ YouTube: https://www.youtube.com/channel/UCv7uTpsGXvSNzwSX_xOtYSA Legal notice: https://immatics.com/imprint/
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
CorTechs Labs is a developer of a brain image analysis software used to offer better clinical insight through quantitative imaging.
Progressive Care provides prescription pharmaceuticals specializing in anti-retroviral patient management, long-term care, and DME.
ChemBridge is a global provider of enabling chemistry products and contract research services
Protein Evolution's goal is to help the chemicals industry transition to a lower-carbon, circular economy. By combining advancements in natural science with artificial intelligence, Protein Evolution's technology breaks down various types of plastic waste efficiently and produces good-as-new, high-quality material as a result – helping companies, communities and governments meet their sustainability goals and reduce their reliance on fossil fuels. Protein Evolution is based in New Haven, CT and partners with ESPCI Paris and 4Catalyzer. The company was founded in 2021 by Yale University alumni Connor Lynn and Scott Stankey, in partnership with Dr. Jonathan Rothberg, a world-renowned scientist, entrepreneur and National Medal of Technology and Innovation recipient.
LifeMine Therapeutics is reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere. Through its proprietary, evolutionarily-derived genomic drug discovery platform, LifeMine aims to bring unparalleled speed, predictability and scalability to small molecule drug discovery. LifeMine has discovered, in genomic space, hundreds of potentially high-impact drug candidates relevant to targets across all major disease areas, and has an initial focus on advancing highly impactful precision medicines in oncology and immune modulation. The Company was founded in 2017 by renowned entrepreneur/scientists Gregory Verdine, Ph.D., and Richard Klausner, M.D., and entrepreneur/company-builder WeiQing Zhou.
EcoPesticides International is a New Mexico Startup Factory company
Pplatform for expediting Laboratory Outsourcing and Scientific Procurement
